International Patent: HETERODIMERIC ANTIGEN-BINDING MOLECULES THAT BIND TO VIRAL PARTICLES AND USES THEREOF

GENEVA, July 2 -- REGENERON PHARMACEUTICALS, INC. filed a patent application (US2025/056614) for “HETERODIMERIC ANTIGEN-BINDING MOLECULES THAT BIND TO VIRAL PARTICLES AND USES THEREOF”. With publication no. WO/2026/112457, here are the other details related to the patent application:

Kind: Later publication of international search report [A3]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....